Total Payments
$9,898
2024 Payments
$3,124
Companies
28
Transactions
587
Medicare Patients
1,303
Medicare Billing
$859,278
Payment Breakdown by Category
Food & Beverage$9,853 (99.5%)
Education$44.69 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,853 | 585 | 99.5% |
| Education | $44.69 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,594 | 115 | $0 (2024) |
| ABBVIE INC. | $1,189 | 76 | $0 (2024) |
| Janssen Biotech, Inc. | $1,081 | 55 | $0 (2024) |
| PFIZER INC. | $787.93 | 56 | $0 (2024) |
| Horizon Therapeutics plc | $755.16 | 57 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $686.63 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $604.89 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $600.95 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $571.47 | 23 | $0 (2024) |
| UCB, Inc. | $474.67 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,124 | 187 | Amgen Inc. ($631.47) |
| 2023 | $2,547 | 147 | ABBVIE INC. ($424.88) |
| 2022 | $2,094 | 121 | Janssen Biotech, Inc. ($436.65) |
| 2021 | $2,133 | 132 | Amgen Inc. ($312.78) |
All Payment Transactions
587 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Immunology | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 11/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $23.94 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Bone Health | ||||||
| 11/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 943 | 77,773 | $2.3M | $824,695 |
| 2022 | 3 | 360 | 524 | $109,253 | $34,582 |
Total Patients
1,303
Total Services
78,297
Medicare Billing
$859,278
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 49 | 12,575 | $1.0M | $423,433 | 42.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 32 | 45,600 | $547,200 | $172,653 | 31.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 48 | 3,360 | $100,800 | $62,328 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 362 | 788 | $154,448 | $54,450 | 35.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 11 | 10,400 | $104,000 | $48,918 | 47.0% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 15 | 4,050 | $295,750 | $40,277 | 13.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 55 | 97 | $26,481 | $7,593 | 28.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 63 | 155 | $20,615 | $6,067 | 29.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 60 | 102 | $47,355 | $3,630 | 7.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 110 | 343 | $15,092 | $2,989 | 19.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 24 | 84 | $5,460 | $1,467 | 26.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 60 | 107 | $963.00 | $576.05 | 59.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 16 | 16 | $272.00 | $146.02 | 53.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 11 | 19 | $931.00 | $83.23 | 8.9% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 13 | 21 | $105.00 | $61.65 | 58.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 14 | 56 | $1,248 | $23.52 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 405 | $79,380 | $32,030 | 40.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 40 | 57 | $29,315 | $2,207 | 7.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 38 | 62 | $558.00 | $345.66 | 61.9% |
About Dana Mann, FNP-BC
Dana Mann, FNP-BC is a Family healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1972995314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dana Mann, FNP-BC has received a total of $9,898 in payments from pharmaceutical and medical device companies, with $3,124 received in 2024. These payments were reported across 587 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,853).
As a Medicare-enrolled provider, Mann has provided services to 1,303 Medicare beneficiaries, totaling 78,297 services with total Medicare billing of $859,278. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Louisville, KY
- Active Since 02/23/2015
- Last Updated 04/13/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1972995314
Products in Payments
- KRYSTEXXA (Biological) $922.09
- RINVOQ (Biological) $891.84
- Enbrel (Biological) $859.64
- TREMFYA (Drug) $837.01
- XELJANZ (Drug) $787.93
- ORENCIA (Biological) $686.63
- BENLYSTA (Biological) $604.89
- SAPHNELO (Biological) $571.47
- Cimzia (Drug) $398.51
- TALTZ (Drug) $387.00
- COSENTYX (Drug) $337.24
- EVENITY (Biological) $296.63
- COSENTYX (Biological) $226.13
- SKYRIZI (Biological) $222.34
- REMICADE (Biological) $192.54
- TAVNEOS (Drug) $179.63
- STRENSIQ (Biological) $177.31
- Strensiq (Drug) $167.02
- PURIFIED CORTROPHIN GEL (Drug) $158.60
- LUPKYNIS (Drug) $149.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Louisville
Ruth Carrico, Rn, Msn, Phd, RN, MSN, PHD
Family — Payments: $403,371
Family $403,371
Ms. Smita Ranjan, Aprn, APRN
Family — Payments: $75,893
Family $75,893
Ashley Knable, Arnp, ARNP
Family — Payments: $75,423
Family $75,423
Danielle Revert, Aprn, APRN
Family — Payments: $64,469
Family $64,469
Mrs. Kassandra Green, Aprn, APRN
Family — Payments: $53,897
Family $53,897
Dr. Tracey Gaslin, Aprn, APRN
Family — Payments: $50,759
Family $50,759